List of Award Recipients

Dr. Phil Wells is a Hematologist. He is currently a University of Ottawa Distinguished Research Chair in Translational and AI Research in Venous Thrombosis. He is perhaps best known for pioneering the concept of clinical prediction rules: the “Wells Model for DVT” and the “Wells Model for PE” are taught and used world-wide. He has received over $30 million in peer reviewed research funding and has over 380 publications. His work has been acknowledged through a Canada Research Chair, and several lifetime achievement awards. His current interests are Cancer Associated Thrombosis and AI to improve or develop clinical predictive analytics.

Dr. Stephen Ferguson is an internationally recognized leader in the Molecular Pharmacology of G protein coupled receptors (GPCRs) whose ground-breaking research contributions have tremendously advanced our current understanding of GPCR trafficking and physiology. GPCRs account for the majority of drug targets and Dr. Ferguson’s research focuses on understanding how GPCR trafficking and altered pharmacological regulation, contribute to disease progression and treatment in hypertension, mental health and neurodegenerative disease such as Alzheimer’s and Huntington’s disease. He is the founder of the Annual Great Lakes GPCR retreat that provides trainees with networking opportunities and showcases the excellence of Canadian science.

A philosopher, neuroscientist and psychiatrist, Dr. Northoff conducts his research where the three fields intersect. He is one of the leading founders and originators of non-reductive neurophilosophy, a field bringing together the empirical science of the brain and conceptual matters such as emotions and other mental features associated with the mind. In studying the relationship between the brain and mind, Dr. Northoff explores how the neural mechanisms of the brain allow it to construct subjective phenomena like the self, consciousness and emotions. He also examines how these mechanisms change through psychiatric disorders such as depression and schizophrenia. His work exploring the brain-mind connection has had global impact in the field of mental health. His research is leading not only to a better understanding of our mental features like self and consciousness, but more importantly, to a less subjective, more objective diagnosis of psychiatric disorders like schizophrenia and depression. With these developments as a stepping stone, Dr. Northoff devises more precise, non-pharmacological therapies for these disorders; for example, he has pinpointed novel targets in the brain useful in the treatment of depression. Dr. Northoff is a full professor the Department of Psychiatry, a clinician-scientist with the Institute of Mental Health Research at The Royal (IMHR), holding the Tier 1 Canada Research Chair for Mind, Brain Imaging and Neuroethics.

Dr. Bell is a professor in the Department of Medicine at the University of Ottawa, a Senior Scientist at The Ottawa Hospital Research Institute and the Scientific Director of BioCanRx.

He is one of the visionary scientists behind a revolutionary approach to fighting cancer by developing oncolytic viruses (OVs) as a therapeutic for cancer. He made the discovery that vesicular stomatitis virus is a potent oncolytic virus. These cancer-killing OVs have the potential to dramatically reduce the morbidity and mortality related to cancer and its treatment and improve the quality of life for patients and their families.

Not only has Dr. Bell pioneered the development of OV platforms, but he is a world-leader in the translation of this technology into the cancer clinic by bridging the necessary expertise, infrastructure and collaborative networks. To date, Dr. Bell’s research has led to the initiation of clinical trials with three different OV platforms, ranging from Phase I to Phase III, in Canada, the U.S, and other countries. Dr. Bell is considered a world leader fighting cancer with oncolytic viruses.

With this award, the Society for Medical Decision Making recognizes Dr. Coyle for his seminal work in medical decision making. Dr. Coyle is a Full Professor in the School of Epidemiology and Public Health.  He is an economist and his research centres on the methods of conducting economic evaluation of health care interventions and he was one of the primary authors on the Canadian guidelines for economic evaluation.  Dr. Coyle has acted as an advisor for many organizations, including CADTH, Health Canada, the Public Health Agency of Canada and various provincial ministries of health with respect to methodology of economic evaluation and in reimbursement decisions relating to health care interventions.

The CFAS Award of Excellence in Reproductive Medicine is an honour reserved for members of the Canadian Fertility and Andrology Society for an outstanding contribution to and leadership in the field of Reproductive Medicine and Science. Dr. Jay Baltz is a Professor in the Department of Obstetrics and Gynecology and Senior Scientist in the Chronic Disease Program at the Ottawa Hospital Research Institute. Dr. Baltz is a specialist in the field of reproduction and developmental biology and his lab focuses on mammalian oocyte growth and maturation and early embryo development.

With this award, the Canadian Society of Cardiovascular Nuclear and CT Imaging recognizes Dr. Beanlands for his outstanding career contributions to the CNCT. Dr. Beanlands is Vered Chair and Chief of the Division of Cardiology at the University of Ottawa Heart Institute and The Ottawa Hospital and Professor in the Division of Cardiology in the Department of Medicine at the University of Ottawa. He is a Tier 1 uOttawa Chair in Cardiovascular Imaging Research. He is an international leader in cardiovascular imaging and founding Director of the National Cardiac PET Centre – the only PET facility in Canada dedicated to cardiovascular disease. His research on cardiac metabolism, flow, cellular and neurohormonal function has led to pioneering translational work that has impacted understanding and the diagnosis of cardiovascular diseases, application in patient care, health policy and guidelines.

With this award, the BSC celebrates and acknowledges Dr. Baenziger’s leadership as President of the BSC from 2014 until 2019, when the society grew from less than 20 to over 300 members. During his mandate, Dr. Baenziger led the modernization of the BSC activities, including revitalizing the BSC website, implementing an annual BSC national meeting, updating the Constitution/Bylaws and establishing a set of awards for trainees and established researchers. Dr. Baenziger is a Professor in the Department of biochemistry, Microbiology and Immunology.  His lab uses a variety of biophysical tools to study the structure and function of a superfamily of proteins (pLGICs), aiming to understanding how they are modulated during both normal and abnormal brain function, with the goal of developing new strategies to correct the altered synaptic communication that occurs in diseased states.

The Robyn Allen Leadership Award recognized an individual who has made a unique contribution to the lives of Canadians with food allergy. Dr. Alqurashi is a pediatric emergency physician at CHEO and investigator at the CHEO Research Institute. His work focuses on advancing knowledge and care of pediatric anaphylaxis and his research has uncovered significant clinical predictors for determining increased risk of biphasic anaphylaxis. Dr. Alqurashi also leads the Canadian Anaphylaxis Network, a national study funded by the CIHR to help inform clinical guidance on biphasic anaphylaxis. Dr. Alqurashi has been unfailing in his commitment to improving the management of anaphylaxis. He has championed initiatives to address knowledge gaps among physicians and patients in treating anaphylaxis. He authored the Anaphylaxis Bottom-Line Recommendations, a highly accessible and user-focused knowledge resource that includes bilingual educational videos for health professionals and families across Canada. He developed the Anaphylaxis PedsPac for use by clinicians treating children with anaphylaxis, which includes a treatment algorithm, pocket card and order sets.

The Tony Pawson Award recognized remarkable achievements on the fundamental understanding and/or practice of proteomics in biological sciences. Dr. Figeys is a Full Professor in the Department of Biochemistry, Microbiology and Immunology and a Distinguished University Research Chair in Proteomics and Systems Biology. He is internationally recognized as an innovator in proteomics, bioanalytical chemistry and systems biology. His seminal contributions are focused on the development of bioanalytical chemistry techniques to study interactions in complex biological systems using proteomics, the large-scale study of proteins. His laboratory led the invention of new technologies and software to better understand these complex systems. He has revolutionized the application of high-throughput technologies based on mass spectrometry and systems biology to study disease and has positioned Canada at the forefront of proteomics and systems research.

The CAHR-CANFAR Excellence in Research Awards are intended to highlight and celebrate the contributions of Canadian researchers in HIV/AIDS research in Canada and internationally. A primary care physician and clinical scientist at the Bruyère Research Institute, Dr. Kendall’s expertise is in epidemiology and health systems, with a focus on primary care for vulnerable populations, particularly people living with HIV. Her work on the Living with HIV Innovation Team (LHIV) and the Participatory Research in Ottawa: Understanding Drugs (PROUD) project has focused on and succeeded in improving the access to and quality of primary care for people living with HIV. These projects confirmed that primary care plays an important role in health care delivery for disadvantaged populations such as patients with HIV and those who use drugs. Dr. Kendall has transformed patient engagement into an art and has built and provides a human dimension to research that transforms the way we address what matters most to patients: their health and the healthcare systems that support them.

This award is granted each year to recognize members of its teaching staff who have earned distinction for themselves and for the University as a result of the importance and exceptional characteristics of their research work. Dr. Grimshaw is a Senior Scientist in the Clinical Epidemiology Program at the Ottawa Hospital Research Institute, a Full Professor in the Department of Medicine at uOttawa and the Tier 1 Canada Research Chair in Health Knowledge Transfer and Uptake. He is one of the world’s foremost implementation researchers. He has produced an innovative, interdisciplinary body of research developing the scientific basis of how to promote the uptake of evidence in healthcare to improve patient outcomes and ensure healthcare system sustainability. His research contributions have informed the policy and practice in Canada and globally.

This award recognizes outstanding commitment of an emerging investigator to advancing inquiry and knowledge of women’s heart, brain and vascular health with the goal of ultimately reducing disease risk and premature death. Dr. Edwards is a rising star in the field of cardiovascular epidemiology and brain-heart connections. In her research, Dr. Edwards addresses a major health challenge: risk assessment and predictive modeling for the brain-heart interface. Her investigations focus on identifying novel cardiac markers of stroke and dementia risk; women’s heart and brain health; and testing new technologies for risk detection. Dr. Edwards is Assistant Professor in the School of Epidemiology and Public Health and Scientist at the University of Ottawa Heart Institute.

The Ricardo Aroca Award is presented to a scientist residing in Canada who has made a distinguished contribution to the field of analytical chemistry while working in Canada. Dr. Figeys is a Full Professor in the Department of Biochemistry, Microbiology and Immunology and a Distinguished University Research Chair in Proteomics and Systems Biology. He is internationally recognized as an innovator in proteomics, bioanalytical chemistry and systems biology. His seminal contributions are focused on the development of bioanalytical chemistry techniques to study interactions in complex biological systems using proteomics, the large-scale study of proteins. His laboratory led the invention of new technologies and software to better understand these complex systems. He has revolutionized the application of high-throughput technologies based on mass spectrometry and systems biology to study disease and has positioned Canada at the forefront of proteomics and systems research.

The Association of Faculties of Medicine of Canada (AFMC) - John Ruedy Award for Innovation in Medical Education is awarded annually to an individual or group who has developed innovative print materials, electronic learning aids or other teaching aids. Dr. Jalali is the head of the Division of Clinical and Functional Anatomy, Department of Innovation in Medical Education and holds the Teaching Chair of the University of Ottawa Faculty of Medicine. He has a Medical Doctorate and a Specialist Diploma in Sports Medicine from the University of Liège in Belgium. Since coming to the Faculty of Medicine in 2003, he has been teaching Anatomy and has developed an active research program in Educational Innovations use and usefulness: Podcasts, YouTube, TBL, Social Media, and 3D printing.

The Ottawa Awards recognize over 300 categories of professionals and businesses that make our city world-class.  These are people’s choice awards and voted on by the public.  Dr. Kwadwo Kyeremanteng is an Assistant Professor in the Department of Medicine, in the Divisions of Critical Care and Palliative Care, and an Associate Scientist at the Ottawa Hospital Research Institute.  He has quickly established himself as a leader in the study of Health Services Research, particularly as it pertains to resource utilization and costs in the Intensive Care Unit and in Palliative Care.  During the COVID-19 pandemic, Dr. Kyeremanteng has been very active in the media discussing the various tolls the pandemic has taken on residents.

Dr Terrence Ruddy was recognized as a Fellow of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in June 2020. The SNMMI Fellowship Program recognizes members of SNMMI for their service to the SNMMI and for their outstanding contributions to the field of nuclear medicine and molecular imaging. 

Dr. Terrence Ruddy is Director of Nuclear Cardiology at the University of Ottawa Heart Institute, Professor in the Departments of Medicine and Radiology at the University of Ottawa and former University Chair and Head of the Divisions of Cardiology and Nuclear Medicine. He is a Clinician-Investigator and an international leader in cardiovascular nuclear medicine. His research focuses on the development and validation of imaging techniques using SPECT and PET radiotracers for the diagnosis and evaluation of cardiovascular disease.

Dr Terrence Ruddy was recognized as a Master of the American Society of Nuclear Cardiology (MASNC) in September 2020. The Masters designation is reserved for distinguished leaders the field of nuclear cardiology, including those who have held senior leadership positions within the American Society of Nuclear Cardiology (ASNC). ASNC is the international leader in education, advocacy, and quality in Nuclear Cardiology and Cardiovascular Computed Tomography, with over 4,200 members worldwide.

Dr. Terrence Ruddy is Director of Nuclear Cardiology at the University of Ottawa Heart Institute, Professor in the Departments of Medicine and Radiology at the University of Ottawa and former University Chair and Head of the Divisions of Cardiology and Nuclear Medicine.  He is a Clinician-Investigator and an international leader in cardiovascular nuclear medicine. His research focuses on the development and validation of imaging techniques using SPECT and PET radiotracers for the diagnosis and evaluation of cardiovascular disease.

The Royal Society is a self-governing Fellowship made up of the most eminent scientists, engineers and technologists from the UK and the Commonwealth. Fellows are elected for life through a peer review process based on excellence in science. Each candidate is considered on his or her own merits and can be proposed from any sector of the scientific community. An internationally renowned thought leader in regenerative medicine, stem cell biology and molecular genetics, Dr. Rudnicki’s groundbreaking research has provided seminal insights into the mechanisms that govern stem cell function, and translated these discoveries towards clinical application. His paradigm-shifting discovery of muscle stem cells transformed our understanding of muscle development and opened the door to new therapeutic strategies to treat neuromuscular disease. His research has fueled the development of novel molecular and stem cell-based approaches for the treatment of muscular dystrophy and other neuromuscular disorders. Dr. Rudnicki’s contributions stand out in a heavily researched field for their clarity and impact on satellite cell function and the wider field of stem cell biology.

Dr. Lyne Pitre is a Family Physician and Director of Medical Education at l’Hôpital Montfort. Franco-Ontarian Dr. Lyne Pitre has shaped a remarkable career as a physician and educator, championing French in medicine. She trained more than 200 family physicians in her career, and through her clinic brought French-language health care to Francophones across Ontario.

This award is granted each year to recognize members of its teaching staff who have earned distinction for themselves and for the University as a result of the importance and exceptional characteristics of their research work. Dr. Vanderhyden is a Senior Scientist in the Cancer Therapeutics Program at OHRI and a Professor in the Department of Cellular and Molecular Medicine. She is a leader, a role model and an agent for change in the cancer research landscape.  Her scientific passion includes the study of female fertility and the consequences when the health of the ovary fails (infertility, cancer).  As Corinne Boyer Chair of Ovarian Cancer Research, she heads an internationally renowned research team that is improving the early diagnosis and treatment of ovarian cancer.

This award recognizes an outstanding research effort by an early-career researcher in the field of sleep research. Dr. Tetyana Kendzerska is an Assistant Professor, Division of Respirology, Department of Medicine and an Associate Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute. Dr. Kendzerska research interests include epidemiology of sleep apnea, particularly the relationship between sleep apnea and other diseases such as cardiovascular disease, diabetes, depression and cancer, the epidemiology of chronic obstructive pulmonary disease and the role of sleep-related disorders in modulating the health consequences of chronic disease.

This award recognizes the outstanding achievement of one of our alumni members within the last year. Consideration is given to alumni who have won honours in their field or who have been recognized nationally or internationally. Dr. Beanlands is Vered Chair and Chief of the Division of Cardiology at the University of Ottawa Heart Institute and The Ottawa Hospital and Professor in the Division of Cardiology in the Department of Medicine at the University of Ottawa. He is a Tier 1 uOttawa Chair in Cardiovascular Imaging Research. He is an international leader in cardiovascular imaging and founding Director of the National Cardiac PET Centre – the only PET facility in Canada dedicated to cardiovascular disease. His research on cardiac metabolism, flow, cellular and neurohormonal function has led to pioneering translational work that has impacted understanding and the diagnosis of cardiovascular diseases, application in patient care, health policy and guidelines.

The objective of the Canadian Academy of Health Sciences is to provide assessments of, and advice on, key issues relevant to the health of Canadians. To this purpose, Fellows well recognized by their peers nationally and internationally are elected to the Academy. The elected Fellows have demonstrated leadership, creativity, distinctive competencies & background, and a commitment to advance academic health science. Dr. Vanderhyden is a Senior Scientist in the Cancer Therapeutics Program at OHRI and a Professor in the Department of Cellular and Molecular Medicine. She is a leader, a role model and an agent for change in the cancer research landscape. Her scientific passion includes the study of female fertility and the consequences when the health of the ovary fails (infertility, cancer). As Corinne Boyer Chair of Ovarian Cancer Research, she heads an internationally renowned research team that is improving the early diagnosis and treatment of ovarian cancer.

The objective of the Canadian Academy of Health Sciences is to provide assessments of, and advice on, key issues relevant to the health of Canadians. To this purpose, Fellows well recognized by their peers nationally and internationally are elected to the Academy. The elected Fellows have demonstrated leadership, creativity, distinctive competencies & background, and a commitment to advance academic health science. Dr. Fergusson is Full Professor with the Department of Medicine and the School of Epidemiology and Public Health. He also holds the OHRI/uOttawa Endowed Chair and is Director and Senior Scientist, Clinical Epidemiology Program, at the Ottawa Hospital Research Institute. Dr Fergusson’s clinical research interests are mainly in the field of transfusion medicine with a focus on transfusion alternatives and the effectiveness of blood products. His research interests also extend to the methodology and ethics of clinical trials and systematic reviews. He also co-leads of the Rethinking Clinical Trials (REaCT) Program which performs practical patient-focused research that ensures that patients receive optimal, safe, cost effective treatment.

NanoOntario provides information on nanoscience and nanotechnology in Ontario. The NanoOntario Awards in Nanosciences rewards scientists and researchers for their accomplishments. Dr. Eve Tsai is a Clinician-Scientist in the OHRI’s Neuroscience Program and Associate Professor of Surgery. Her research focuses on spinal cord and brain repair strategies, axonal regeneration, MRI imaging of spinal cord tracts in humans and animals, stroke, and clinical outcomes after spine surgery. In 2010, Dr. Tsai won Canada’s Top 40 Under 40 Award^TM, which honours achievement for vision and leadership; innovation and achievement; impact; growth/development strategy; and community involvement and contribution. In both 2012 and 2013, Dr. Tsai was selected by committee as one of the Top 25 Women of Influence by Women of Influence Magazine.

This award recognizes a physician who produced important clinical or educational research in emergency medicine within the past three years. Dr. Christian Vaillancourt is Full Professor and Clinical Research Chair (Tier 1) in Emergency Heart and Brain Resuscitation, Department of Emergency Medicine, Senior Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute and Associate Medical Director, Regional Paramedic Program for Eastern Ontario. Dr. Vaillancourt in an international expert in the field of sudden unexpected cardiac death. His most notable contributions are in the care of prehospital/out-of-hospital cardiac arrest victims.

This award recognizes a ACR member over 65 for outstanding service to patients or outstanding administrative service or excellence in rheumatology teaching and education or excellence in rheumatology research. Dr. Ciaran Duffy is Professor and Chair, Department of Pediatrics and Chief of Pediatrics, Children’s Hospital of Eastern Ontario (CHEO). His research focuses on pediatric rheumatology with a particular interest in juvenile idiopathic arthritis (JIA). He leads large cohort studies in JIA – REACCH OUT and LEAP – nationally, has published extensively in this area, mostly on quality of life (QOL) of JIA children. He developed tools to evaluate QOL, the Juvenile Arthritis Quality-of-life Questionnaire (JAQQ) being the most employed in clinical studies regarding QOL or treatments.

This award rewards a Canadian MD or PhD medical scientist who has made significant contributions to new knowledge and is recognized as an expert, innovative, and in the forefront of research endeavour.  Dr. John Bell is a Full Professor in the Departments of Medicine and Biochemistry, Microbiology and Immunology (BMI) and a Senior Scientist with the Ottawa Hospital Research Institute Cancer Therapeutics Program. His research focuses on oncolytic viruses as a new therapeutic for cancer. He heads the Canadian Oncolytic Virus Consortium, a Terry Fox funded group from across Canada and is the Director of the Ontario Regional Biotherapeutics Program for the Ontario Institute for Cancer Research. He is the Scientific Director of BioCanRx, a Network of Centres of Excellence. Dr. Bell is a fellow of the Royal Society of Canada.

The APUO Award for Excellence in Teaching is an award sponsored by the University of Ottawa and the Association of Professors of the University of Ottawa (APUO). It recognizes outstanding contributions to university teaching. Dr. Jalali is the head of the Division of Clinical and Functional Anatomy, Department of Innovation in Medical Education and holds the Teaching Chair of the University of Ottawa Faculty of Medicine. He has a Medical Doctorate and a Specialist Diploma in Sports Medicine from the University of Liège in Belgium. Since coming to the Faculty of Medicine in 2003, he has been teaching Anatomy and has developed an active research program in Educational Innovations use and usefulness: Podcasts, YouTube, TBL, Social Media, and 3D printing.

The Assembly on Sleep and Respiratory Neurobiology of the American Thoracic Society focuses on sleep-related breathing disorders. Their James B. Skatrud New Investigator Award recognizes the career accomplishments to date and future promise of a new investigator working in the broad area of respiratory neurobiology and sleep. Dr. Tetyana Kendzerska is an Assistant Professor, Division of Respirology, Department of Medicine and an Associate Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute. Dr. Kendzerska research interests include epidemiology of sleep apnea, particularly the relationship between sleep apnea and other diseases such as cardiovascular disease, diabetes, depression and cancer, the epidemiology of chronic obstructive pulmonary disease and the role of sleep-related disorders in modulating the health consequences of chronic disease.

This award recognizes people, organizations or teams who carry a vision for positive change and the potential to make notable impact for patients and caregivers. One of the 2020 recipient is the eConsultBASE ^TM service, a secure online application that connects primary care providers with specialists, allowing them to receive prompt advice on behalf of their patients using a technology already available in the region, now expended throughout Ontario. Dr. Clare Liddy is Chair and Associate Professor in the Department of Family Medicine, a Clinical Investigator at the C.T. Lamont Primary Health Care Research Centre, a Senior Researcher at the Bruyère Research Institute and a family physician at the Ottawa Hospital Academic Family Health Team. She is the Primary Care Lead for the eConsultBASE ^TM service and the Co-Executive Director of the Ontario eConsult Centre of Excellence, which is managing the expansion of eConsult across Ontario.

The uOttawa Alumni Association Awards of Excellence recognize the achievements of University of Ottawa Alumni. The Honorary Member Award celebrates friends of uOttawa who are not a graduate of the University for outstanding personal service, commitment, and contribution, past or present, to the University. Dr. Robert Korneluk is Professor in the Departments of Pediatrics and Biochemistry, Microbiology and Immunology and a Senior Scientist and the Scientific Director of the Apoptosis Research Centre at the Children’s Hospital of Eastern Ontario (CHEO) Research Institute. His research focuses on the aspects of apoptosis and its role in cancer. He is a Fellow of the Royal Society of Canada and has received the prestigious McLaughlin Medal from the Royal Society of Canada for achievement in medical research. Dr. Korneluk is also a Member of the Order of Canada.

The Professional Association of Residents of Ontario (PARO) is the official representative voice for Ontario’s doctors in training. The PARO Excellence in Clinical Teaching Award acknowledges the essential role that good clinical teachers play in the training of new physicians. Dr. Jason Leclair is an Assistant Professor with the Department of Family Medicine and is a co-director of the Family Medicine Inpatient Teaching Services at The Ottawa Hospital. His main interests include medical education, hospital metrics, and evidence-based practices in sclerotherapy. Dr. Leclair has a primary care practice at the Central Ottawa Family Medicine Associates and has a community family medicine resident at his office.

The Association of Faculties of Medicine of Canada (AFMC) – Clinical Teacher Award emphasizes the importance of excellence in clinical teaching and recognizes an individual in Canada who has provided exceptional clinical teaching contribution. Dr. Bell has been a Professor with the Faculty of Medicine since 1988 and has shown himself to be an essential contributor to the education of our medical students, demonstrating vision, innovation and leadership in clinical teaching in our Faculty. He is one of our most active teachers at the Undergraduate, Postgraduate and higher levels in medical education, most notably as a renal content expert.

This award recognizes researchers that have conducted a successful and innovative project in promoting and facilitating the use of research outside academia. Dr. Lynne Leonard is a social epidemiologist and Assistant Professor and Research Scientist in the School of Epidemiology and Public Health. Her work focuses on HIV prevention, through the lens of social policy, epidemiology and biostatistics. Dr. Leonard is particularly interested in the social determinants of health and in conducting community-based research to effect policy and program change at the community, provincial and national level. Dr. Leonard received the award for a community-based drug-checking program at the Oasis Supervised Injection Site (SIS) of the Sandy Hill Community Health Centre in Ottawa. The results of the research, regularly shared with the people who use and inject drugs, the health and legal communities and policy decision makers, has resulted in positive changes in behavior among individual users, such as reducing their dose or alerting others to unsafe drug supplies.

The Kidney Foundation’s John Dossetor Award is presented to an individual or group who merits special recognition for outstanding service or other contributions to the Kidney Foundation’s research program (e.g., significant funding of research, creating/developing research partnerships, raising research awareness, contributing to research committees, etc.).  Dr. Chris Kennedy is a Full Professor in the Departments of Medicine and Cellular and Molecular Medicine and Senior Scientist within the Chronic Disease Program and Kidney Research Centre at the Ottawa Hospital Research Institute.  Dr. Kennedy’s research program seeks to identify how the kidney’s filtration system and vasculature are damaged in diabetes and high blood pressure, the two leading causes of kidney disease in Canada, with the goal of translating his work into novel therapies that would slow or prevent kidney disease progression.

This award is presented on behalf of the CIHR-Institute of Circulatory and Respiratory Health (ICRH) and the Canadian Society of Atherosclerosis, Thombosis and Vascular Biology (CSATVB) to recognize an individual’s outstanding contribution to the advancement of blood and/or blood vessel sciences both in Canada and internationally. Dr. Wells is Professor and Chair of the Department of Medicine and is a world renowned clinician-scientist who has revolutionized the field of venous thromboembolism.  He developed the clinical scoring system for patients suspected of blood clots known as the Wells Model for DVT (legs clots) and the Wells Model for PE (lung clots). The Wells Models have had a major impact on clinical practice and patient care, including significant cost savings to the healthcare system by eliminating unnecessary imaging and reducing emergency department wait times.

This award is presented on behalf of the CIHR-Institute of Circulatory and Respiratory Health (ICRH) and the Canadian Association of Emergency Physicians (CAEP) to recognize significant contributions of mid-career researchers to the advancement of emergency medicine in Canada. Dr. Thiruganasambandamoorthy is Professor of Emergency Medicine and Scientist at OHRI.  His research focuses on cardiac emergencies, predominantly in the management of emergency department syncope and chest pain. His research results have had a signification impact on clinical practice in emergency medicine in Canada and internationally.

This distinction aims to recognize the exceptional contribution of members of the First Nations and the Inuit Nation.  In addition, this recognition highlights the journey of remarkable people who, through their achievements and their commitment, contribute to the influence of their community, their nation or First Peoples across Quebec or Canada or even internationally. An Assistant Professor in the Department of Family Medicine, Dr. Darlene Kitty teaches and develops Indigenous health curricula including academic activities in Indigenous health and several specialty programs.

These awards are presented annually by Health Promotion Canada to elevate and acknowledge health promoters at various stages in their careers and celebrate those who are making significant contributions in the field of health promotion across Canada.  Dr. Potvin Kent is an Associate Professor in the School of Epidemiology and Public Health and has emerged as a leading expert in food and nutrition policy in Canada, particularly focused on food and beverage marketing to children and adolescents. Working with various stakeholders, Dr. Potvin Kent is actively translation her work for all audiences outlining the persuasive and dangerous nature of food marketing to children. Her work provides important evidence to NGOs and the federal government to enact laws and regulations to protect children from unhealthy food and beverage marketing.

This award is given to researchers with outstanding achievements in knowledge translation in aging at a local or regional level. Knowledge translation involves the conversion of research into clinical practice—something that Dr. Barbara Farrell has excelled at through her work in deprescribing. Deprescribing is the planned and supervised process of stopping or reducing medications that may be causing harm or may no longer be of benefit. Since 2013, Dr. Farrell and the Bruyère Deprescribing Research Team have worked tirelessly to address challenges related to polypharmacy and improving medication-related care for older adults. Dr. Barbara Farrell, is currently a scientist with the Bruyère Research Institute (BRI) and the CT Lamont Primary Health Care Research Centre, and an Assistant Professor with the Department of Family Medicine at the University of Ottawa.

Fellows of the Academy are elected on the basis of their demonstrated leadership, creativity, distinctive competencies and commitment to advance academic health sciences. Dr. Mark Tremblay is Director of Healthy Active Living and Obesity Research at the CHEO Research Institute, Full Professor of Pediatrics at the University of Ottawa, and an internationally renowned researcher in pediatric exercise science. He is among the mostly highly cited (top 1%) and sought after scientists in the world in childhood healthy active living leadership, research, education and training, and advocacy. He is the founder and President of the Active Healthy Kids Global Alliance, the Sedentary Behaviour Research Network, and cofounder of Outdoor Play Canada.

Fellows of the Academy are elected on the basis of their demonstrated leadership, creativity, distinctive competencies and commitment to advance academic health sciences. Dr. David Moher is a Senior Scientist in the Clinical Epidemiology Program of the Ottawa Hospital Research Institute and Associate Professor in the School of Epidemiology and Public Health. Dr. Moher is an internationally recognized leader and pioneer in the conduct of randomized clinical trials, methodology of systematic reviews and meta-analyses, developing guidelines for reporting health research, and for pioneering the emerging field of journalology (publication science). He is one of the most cited and impactful researchers in the world.

The College of New Scholars, Artists and Scientists is Canada’s first national system of multidisciplinary recognition for the emerging generation of Canadian intellectual leadership. It comprises a fourth entity (along with the current three Academies) within the Royal Society of Canada. Dr. Katey Rayner is Principal Investigator at the University of Ottawa Heart Institute and Director of the Cardiometabolic microRNA Laboratory. She is an internationally recognized leader in the cellular and molecular mechanisms driving cardiovascular disease, and her work has identified novel microRNA- and inflammatory-based mechanisms that contribute to atherosclerosis and obesity. Her work has significant translational implications on the development of novel therapeutics and diagnostic tests to identify at-risk individuals.

Fellows of the RSC are distinguished women and men from all branches of learning who have made remarkable contributions in the arts, the humanities and the sciences, as well as in Canadian public life. Dr. Grimshaw is a Senior Scientist in the Clinical Epidemiology Program at the Ottawa Hospital Research Institute, a Full Professor in the Department of Medicine at uOttawa and the Tier 1 Canada Research Chair in Health Knowledge Transfer and Uptake. He is one of the world’s foremost implementation researchers. He has produced an innovative, interdisciplinary body of research developing the scientific basis of how to promote the uptake of evidence in healthcare to improve patient outcomes and ensure healthcare system sustainability. His research contributions have informed the policy and practice in Canada and globally.

Fellows of the RSC are distinguished women and men from all branches of learning who have made remarkable contributions in the arts, the humanities and the sciences, as well as in Canadian public life.  Dr. Kym Boycott, a Professor of Pediatrics at uOttawa, Clinical Geneticist at CHEO, and Senior Scientist at CHEO Research Institute, is a visionary in employing genomics to understand molecular mechanisms of rare disease. She leads Care4Rare Canada, an internationally-renowned platform that has identified the genetic cause of 460 rare diseases while discovering 125 new genes. She also leads international initiatives to advance global cooperation and data sharing in rare disease.

The Meridith Marks Mentorship Award recognizes an individual who excels in the mentorship of those involved in medical education scholarship and innovation. Dr. Susan Humphrey-Murto is a Professor in the Department of Medicine and is highly active in medical education at a national level and within the University of Ottawa. She also has several ongoing research projects covering topics such as performance-based assessment, feedback, consensus research methods and emotional intelligence.

The award, based on the evaluation of his or her peers, honors scholarly achievements and contributions to knowledge about mechanisms of neural repair, translational research from mechanisms of repair to clinical practice, or clinical Neurorehabilitation. Dr. Dale Corbett is a Professor of Neurosciences in the Department of Cellular and Molecular Medicine, whose research program concerns the recovery of sensory-motor and cognitive function following stroke.  His lab uses a variety of approaches to enhance neuroplasticity and stroke recovery including novel forms of rehabilitation, exercise and mobilization of endogenous neural precursors and stem cells.

This honour is conferred as a way of honouring a distinguished visitor’s contributions to a specific field of to society in general. Dr. Jasmin has been awarded the Docteur Honoris Causa in recognition for his outstanding academic leadership, innovative research contributions and dedicated partnership development.

This award honours researchers who have been successful and innovative in promoting the use of research outside of academia.  Dr. Kulkarni’s recent research has focused on identifying areas in and around Ottawa that are at greater risk for Lyme disease and West Nile virus, and using this information to inform local public policy to develop current assessment and clinical management of exposure.  Based on tick surveillance and lab analyses, Dr. Kulkarni and her team have developed Lyme disease risk maps across the city, and are working with partners such as Ottawa Public Health and the National Capital Commission to inform the public and work towards reducing tick densities on recreational trails.

The rank of Distinguished University Professor is awarded in recognition of outstanding scholarly achievements at the University of Ottawa and preeminence in their own field of research.  Dr. Manuel’s research combines his interests in public health, health care systems and primary care. He collaborates to tackle question such as, how long will Canadian's live and what are the most effective strategies to improve our communities health and reduce inequities. Over the past 25 years, he has answered these questions by developing Canada’s strength in big health data and by building advanced predictive health models. His exceptional work at University of Ottawa and the Ottawa Hospital reflects the outstanding research opportunities with Canada’s largest academic hospital combined with federal agencies and their expertise collecting and using the nation’s health data. 

This award was created in recognition of research excellence and is offered to an established investigator working on an aspect of cardiovascular research in Canada. Dr. Ruth McPherson, MD, PhD, is Director of the Ruddy Canadian Cardiovascular Genetics Centre, Atherogenomics Laboratory and the Lipid Clinic and a member of the Division of Cardiology at the University of Ottawa Heart Institute. She is also a Professor in the Departments of Medicine and Biochemistry at the University of Ottawa. Dr. McPherson co-leads the Ottawa region strategic research Innovation Cluster on Vascular Inflammation and Metabolism.  Dr. McPherson is a leader in cardiovascular genetics, having led the discovery of the 9p21 genetic risk factor for heart disease in 2007. Her research is centred on the discovery and functional analysis of genetic variants linked to cardiovascular disease and its metabolic precedents, including lipid traits and obesity.

This award from the College of Family Physicians of Canada recognizes a family medicine researcher who has made original contributions to research and has been a pivotal force in the definition, development, and dissemination of concepts that are central to the discipline of family medicine in Canada. This is a program of the Foundation for Advancing Family Medicine, through the generosity of its donors.​ Dr. Clare Liddy is a family physician and Associate Professor in the Department of Family Medicine at uOttawa.  With her colleague Dr. Erin Keely, Dr. Liddy developed the Champlain Base^TM eConsult service, a secure online application that connects primary care providers with specialists.  This innovative service allors providers to received prompt advice on behalf of their patients using a technology already available in the region. eConsult has proven to be a success across various healthcare improvement measures including population health, patient experience, provider satisfaction and cost savings.

This prestigious award, sponsored by the University of British Columbia, recognizes a Canadian physician or scientist who makes outstanding contributions to the treatment, amelioration, or cure of heart disorders.  Dr. Ruth McPherson, MD, PhD, is Director of the Ruddy Canadian Cardiovascular Genetics Centre, Atherogenomics Laboratory and the Lipid Clinic and a member of the Division of Cardiology at the University of Ottawa Heart Institute. She is also a Professor in the Departments of Medicine and Biochemistry at the University of Ottawa. Dr. McPherson co-leads the Ottawa region strategic research Innovation Cluster on Vascular Inflammation and Metabolism.  Dr. McPherson is a leader in cardiovascular genetics, having led the discovery of the 9p21 genetic risk factor for heart disease in 2007. Her research is centred on the discovery and functional analysis of genetic variants linked to cardiovascular disease and its metabolic precedents, including lipid traits and obesity.

This prize, sponsored by CIHR and the Canadian Cardiovascular Society, recognizes outstanding researchers within the Institute of Circulatory and Respiratory Health scientific research community.  Dr. Beanlands is Vered Chair and Chief of the Division of Cardiology at the University of Ottawa Heart Institute and The Ottawa Hospital and Professor in the Division of Cardiology in the Department of Medicine at the University of Ottawa. He is a Tier 1 uOttawa Chair in Cardiovascular Imaging Research. He is an international leader in cardiovascular imaging and founding Director of the National Cardiac PET Centre – the only PET facility in Canada dedicated to cardiovascular disease. His research on cardiac metabolism, flow, cellular and neurohormonal function has led to pioneering translational work that has impacted understanding and the diagnosis of cardiovascular diseases, application in patient care, health policy and guidelines.

The University of Ottawa established this annual prize to recognize educators of exceptional quality, driven by their passion to advance and share knowledge.  Dr. Jean-François Couture is a Professor in the Department of Biochemistry, Microbiology and Immunology. His pioneering work has provided key insights into how epigenetic processes are central to every aspect of cell biology, with focuses on understanding the mechanisms that cause leukemia. Additionally, Dr. Couture is an outstanding educator and mentor, balancing a full teaching load and a multidisciplinary laboratory training for his students.  He also played a critical role in the development of the Faculty’s new Translational and Molecular Medicine (TMM) program as its first director.

Dr. Pakhalé is an Assistant Professor in the Department of Medicine and the School of Epidemiology and Public Health in the Faculty of Medicine, a Scientist with the Ottawa Hospital Research Institute and a Staff Respirologist at The Ottawa Hospital. The SNOW Woman of the Year Award was given to Dr. Pakhale in recognition of her patient engagement model, The Ottawa Citizen Engagement and Action Model (OCEAM), which was designed and operationalized at the Bridge Engagement Centre – a community-based research center she leads in downtown Ottawa. Dr. Pakhale’s research interests include health equity and marginalized populations, Indigenous People’s health and wellbeing as well as Tobacco Dependence Management.

The ESGCT seeks to honour impactful, significant and lasting contributions to the field of gene and cell therapy. This award recognizes outstanding contribution to, and participation in, public and patient stakeholder engagement. Dr. John Bell is a Senior Scientist in the Cancer Therapeutics Program of OHRI and Professor in the Departments of Medicine and Biochemistry, Microbiology and Immunology.  Dr. Bell is also the Scientific Director of BioCanRx, a Network Centre of Excellence, through which he is recognized for his outstanding work towards engaging patients, establishing dialogue and generating learning.  He is committed to engaging research and patient partners in all aspects of the research process and supporting researcher-patient collaborations.

This award recognizes a member of the Society for the Study of Reproduction (SSR) who, as a mentor, has had significant impact on the trainees within SSR, consistently demonstrating a measure of support and guidance that far exceeds the basic responsibilities required of an academic advisor.  Dr. Vanderhyden is a Senior Scientist in the Cancer Therapeutics Program at OHRI and a Professor in the Department of Cellular and Molecular Medicine.  She has mentored over 120 trainees and oversees two science outreach programs: Let’s Talk Science and Science Travels.  This award recognizes her profound impact on the next generation of reproduction biology researchers.

This award presented by the Professional Association of Residents of Ontario acknowledges the essential role that good clinical teachers play in the training of physicians and highlight the qualities that make an excellent teacher: patient care, quality of bedside teaching and interest in the trainees’ personal development and well-being.  Dr. Grynspan is an Assistant Professor in the Department of Pathology and Laboratory Medicine in the Faculty of Medicine and an Investigator with the CHEO Research Institute.

This award presented by the Professional Association of Residents of Ontario is given to one individual who consistently advocates on behalf of residents and resident issues, within their role as an administrator, program coordinator, teacher or clinician. Dr. Thurgur is an Assistant Professor in the Department of Emergency Medicine at the Faculty of Medicine and the Program Director of the University of Ottawa Royal College of Physicians and Surgeons of Canada (RSPSC) Emergency Residency Program.

The Dr. Michael Freeman Canadian Society of Cardiovascular Nuclear and CT Imaging (CNCT) Annual Achievement Award recognizes a CNCT member who has made an outstanding contribution in their career to Cardiovascular Nuclear and/or CT Imaging in Canada. Dr. Ross Davies is a Cardiologist in the Division of Cardiology at UOHI and Professor in the Faculty of Medicine. He initiated the Nuclear Cardiology Program at the Heart Institute and was Director until 1998. His research focuses on cardiovascular databases.

This award recognizes the leadership, commitment, and positive impact of a Franco-Ontarian individual on Ottawa's Francophone community over the past year. Dr. Manon Denis-Leblanc is Vice-Dean, Francophone Affairs and funding member of the Faculty’s Office of Francophone Affairs (OFA). She is also a hospitalist at Hôpital Montfort. Over the years, she has successfully contributed to several OFA initiatives, such as the mini courses that introduce medical principles to the general public. She was also involved in establishing clerkships at Montfort Hospital and set up clerkship positions for Francophones in satellite locations such as Hawkesbury and Shawville. She directed clerkships before become clerkship co-director from 2004 to 2006. She took on several projects to improve efficiency and quality (LEAN Management initiatives at Montfort Hospital and the Champion program for Health Quality Ontario) and has been active in projects involving the migration of electronic files (HealthScreen, PSS, Telus, Meditech).

Resident Doctors of Canada is a not-for-profit organization providing a national voice for residents in Canada. The Mikhael Award for Medical Education recognizes annually someone who contributed to improving undergraduate and postgraduate medical education in Canada. Dr. Warren Cheung is Assistant Professor, Department of Emergency Medicine and Senior Clinician Investigator, Clinical Epidemiology Program, OHRI. He also holds position as Associate Director of Education Innovation, Director of Assessment and Chair, FRCPC Competence Committee for the Department of Emergency Medicine.  His research focuses on improving the quality of trainee assessments within a competency-based framework, with particular interest in studying workplace-based assessments and direct observation of performance.

This award is bestowed to an emerging scientist conducting lipid or lipoprotein research and transitioning to a career as an independent investigator. Dr. Erin Mulvihill is Assistant Professor, Department of Biochemistry, Microbiology and Immunology and Scientist and Director of the Energy Substrate Metabolism Research Laboratory at UOHI. Her research focuses on lipids and lipoproteins, models of diabetes and cardiovascular disease, intestinal biology and mouse genetics. Dr. Mulvihill’s laboratory aspires to contribute to improve our understanding of the molecular events which contribute to metabolic and cardiovascular disease.

America's Network (AMNET) for Chronic Disease Surveillance is a network of public health professionals from the 35 countries that make up the region of the Americas who aim to enhance the capacity of chronic disease surveillance. The Highest Recognition Award was given to Dr. Choi by the AMNET board of directors for his contributions as a founding member of the AMNET and his 16 years with the board of Directors. Dr. Bernard Choi is Adjunct Professor, School of Epidemiology, Public Health and Preventive Medicine, Adjunct Professor, Department of Health Sciences, Carleton University, Associate Professor, Dalla Lana School of Public Health, University of Toronto and Senior Research Scientist, Public Health Agency of Canada. His research focuses on occupational and environmental health, epidemiology and surveillance of chronic diseases and risk factors, knowledge translation, policy research, program evaluation and international health. He has developed a series of statistical procedures for public health.

Election as a Fellow of the American Heart Association recognizes scientific and professional accomplishments, volunteer leadership and service. Dr. Louise Sun is an Assistant Professor of Anesthesiology and Epidemiology and a cardiac anesthesiologist at UOHI. She also is Adjunct Scientist at ICES and the Director of Cardiocore Big Data Research Unit and Team Soleil at UOHI. Her research focuses on leveraging big data to tackle key issues in health care delivery and outcomes for patients with heart failure and/or undergoing cardiovascular interventions.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) Blumgart Award recognizes significant scientific contributions and outstanding achievements in the field of nuclear cardiology. It is the highest honour bestowed from the SNMMI. Dr. Terrence Ruddy is Director of Nuclear Cardiology at UOHI. He is a Professor in the Division of Cardiology in the Department of Medicine and cross-appointed to the Division of Nuclear Medicine in the Department of Radiology, a Clinician-Investigator and an international leader in cardiovascular nuclear medicine. His research focuses on the development and validation of imaging techniques using SPECT and PET radiotracers for the diagnosis and evaluation of cardiovascular disease.

Fellows of the RSC are distinguished women and men from all branches of learning who have made remarkable contributions in the arts, the humanities and the sciences, as well as in Canadian public life. Dr. David Moher is a Senior Scientist in the Clinical Epidemiology Program of the Ottawa Hospital Research Institute and Associate Professor in the School of Epidemiology and Public Health. Dr. Moher is an internationally recognized leader and pioneer in the conduct of randomized clinical trials, methodology of systematic reviews and meta-analyses, developing guidelines for reporting health research and for pioneering the emerging field of journalology (publication science).  He is one of the most cited and impactful researchers in the world.

This award recognizes contributions to the discipline of Health Psychology. Dr. Justin Presseau is an Associate Professor in the School of Epidemiology and Public Health and a Scientist at OHRI. His research program focuses on behaviour change related to health and focuses particularly on developing and evaluating theory-based behaviour change interventions and in understanding the role of habit/automatic behaviour and competing behaviours in the process of behaviour change.

This award was created to emphasize, reinforce and enhance the important of humanistic qualities among medical students and faculty. Dr. Turnbull is Professor of Medicine at the University of Ottawa and the Health Equity Clinical Lead for Health Quality Ontario. He focused much of his early academic attention on issues in medical education, and his caring and compassionate approach to teaching and mentorship has been recognized time and again. In recent years, Dr. Turnbull has turned his attention to the health needs of vulnerable populations, including the homeless in Ottawa. As Medical Director of the Inner City Health Project, he is dedicated to meeting the medical, dental and social needs of those most vulnerable.

The Order of Canada is how our country honours people who make extraordinary contributions to the nation.  Dr. Robert Korneluk is the first CHEO researcher to be appointed to the Order of Canada. With almost 40 years of science under his belt, Faculty of Medicine professor and CHEO Research Institute Senior Scientist Robert Korneluk has helped propel immunotherapy into one of the biggest buzzwords in medicine. In 1995, Dr. Korneluk and his team discovered a family of genes called Inhibitors of Apoptosis (IAPs) that control cell death. This ground-breaking discovery has been the basis of breakthroughs worldwide in cancer, diabetes, neurodegeneration and more. It’s also the basis of his current work exploring how to enhance the immune system’s own natural response to cancers.

The Partners in Research National Awards recognize exemplary and impactful outreach education efforts and research promotion/communication leadership by Canadian researchers, benefitting Canadian elementary and secondary school students and/or the general Canadian public. Dr. Wilson is a specialist in General Internal Medicine at The Ottawa Hospital, whose work focuses on public health innovation including blood safety, immunization and newborn screening. His overall vision is to bring data to patients, clinicians and the public through the use of digital technologies.

The Order of Ottawa recognizes exceptional residents who have made a significant contribution in a professional capacity in many areas of city life, including arts and culture, business, community service, education, public service, labour, communications and media, science, medicine, sports and entertainment, or other fields that benefit the residents of Ottawa. Dr. Marc Ruel is a pioneer in the field of heart surgery, where he has distinguished himself as a top surgeon, researcher, educator, and administrator.  Dr. Ruel is a professor in the University of Ottawa’s Department of Cellular and Molecular Medicine and in the Department of Surgery, where he is also the Head of the Division of Cardiac Surgery. He is the Michael Pitfield Chair in Cardiac Surgery and Chair in Cardiac Surgery Research, and the Surgical Director of the heart transplantation program at the University of Ottawa Heart Institute.  He is also the President-Elect of the Canadian Cardiovascular Society, Canada’s most prestigious cardiovascular organization.

This year's CIHR Barer-Flood Prize for Health Services and Policy Research has been awarded to uOttawa and OHRI's Dr Jeremy Grimshaw! This prestigious award honours exceptional researchers in the area of health services and policy research whose body of work has had a demonstrated impact on health services and policy research, policy and/or care delivery. Dr Grimshaw is a Senior Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute, a Full Professor in the Department of Medicine, University of Ottawa and the Tier 1 Canada Research Chair in Health Knowledge Transfer and Uptake. Dr Grimshaw's innovative research is focused on improving the adoption of evidence-based research by healthcare professionals and systems to improve overall quality of care. Dr Grimshaw is one of the world's top knowledge transfer (KT) scientists and his transformative influence in the rapidly emerging field of knowledge translation and implementation (KTI) can be seen in several key research areas. Heralded for his championing efforts to bridge the gap between research and clinical care, Dr Grimshaw has made enormous contributions to methods and theories of knowledge translation and supports evidence-based reform across Canada and the World.

On October 10, Médecins francophones du Canada presented the award Prix de l'ambassadeur du français en médecine Jacques-Boulay to Dr. Lyne Pitre, a Family Physician and Director of Medical Education at l’Hôpital Montfort.  Created in honour of Dr. Jacques Boulay, an ardent defender of the quality of medical French on the Quebec and French-Canadian scenes during the 1960s, 1970s and 1980s, this award highlights the role played by Dr. Lyne Pitre in the defence of French and her ongoing commitment to the quality of French in medicine.

The George Lyman Duff Memorial Lecture was established in 1956 by the Society for the Study of Arteriosclerosis in memory of Dr. Duff, a founding member and past president of the society. Dr. Duff was one of Canada’s most distinguished pathologists and medical educators. Ruth McPherson, MD, PhD, is Director of the Ruddy Canadian Cardiovascular Genetics Centre, Atherogenomics Laboratory and the Lipid Clinic and a member of the Division of Cardiology at the University of Ottawa Heart Institute. She is also a Professor in the Departments of Medicine and Biochemistry at the University of Ottawa. Dr. McPherson co-leads the Ottawa region strategic research Innovation Cluster on Vascular Inflammation and Metabolism.  Dr. McPherson is a leader in cardiovascular genetics, having led the discovery of the 9p21 genetic risk factor for heart disease in 2007. Her research is centred on the discovery and functional analysis of genetic variants linked to cardiovascular disease and its metabolic precedents, including lipid traits and obesity. Dr. McPherson is the first Canadian to receive this award.

The CSMB New Investigator Award is an annual award established by the Society to recognize meritorious research in biochemistry, molecular or cellular biology or genetics in Canada. Dr. Katey Rayner is Principal Investigator at the University of Ottawa Heart Institute and Director of the Cardiometabolic microRNA Laboratory. She is an internationally recognized leader in the cellular and molecular mechanisms driving cardiovascular disease, and her research program focuses on how microRNAs control multiple aspects of the risk factors that drive both atherosclerosis and obesity, namely inflammation dysregulated energy metabolism, and how microRNAs may be used as therapeutics in the future to treat these cardiometabolic diseases.  Her work has identified novel microRNA- and inflammatory-based mechanisms that contribute to atherosclerosis and obesity. Her work has important translational implications in the development of novel therapeutics and diagnostic tests to identify at-risk individuals.

This award recognizes an OHRI scientist who is the senior author on a stellar publication that is backed by an excellent publication record. Dr. Bill Stanford, a Senior Scientist at the Sprott Centre for Stem Cell Research at the Ottawa Hospital Research Institute, a Full Professor in the Department of Cellular and Molecular Medicine at the University of Ottawa and holder of a Tier 1 Canada Research Chair in Integrative Stem Cell Biology, has been awarded the Chrétien Researcher of the Year Award for his groundbreaking research on stem cells and leukemia, including an upcoming paper with major clinical implications. The focus of Dr. Stanford’s laboratory is to understand and manipulate the behavior of pluripotent and somatic stem cells to understand mechanisms of human disease and develop novel therapeutics. Their research utilizes systems biology to tease apart cell behavior and pathophysiology.

Fellows of the RSC are distinguished men and women from all branches of learning who have made remarkable contributions in the arts, the humanities and the sciences, as well as in Canadian public life. Dr. Pierre Blier is a full professor at the University of Ottawa, Department of Psychiatry and Cellular/Molecular Medicine, and the recipient of the Endowed Chair in Mood Disorders Research at The Royal’s Institute of Mental Health Research (IMHR), affiliated with the University of Ottawa.  As a world-renowned scientist, Dr. Blier’s ground-breaking research focuses on implementing rapid-acting antidepressant strategies, including low-dose ketamine for treatment-resistant depression. He was the first researcher in Canada to begin investigating this new and promising approach to treating depression. He is also one of the ten members of the international task force for devising and implementing a novel neuroscience-based nomenclature for psychotropic medications. Dr. Blier continues to see patients with mood and anxiety disorders on a daily basis.

The Alice Wilson Awards recognize the most outstanding post-doctoral student from among scholarship recipients of each of Canada’s three granting councils. Mahsa Jessri is a CIHR Banting postdoctoral Fellow at the Clinical Epidemiology program, Ottawa Hospital Research Institute. She completed her doctoral studies at the University of Toronto and is trained as a public health nutritionist/dietitian. Dr. Jessri’s research has advanced the knowledge in the area of chronic disease and nutritional epidemiology, providing a robust foundation for informing nutritional policies and guidelines for promoting health at the population level.

The College of New Scholars, Artists and Scientists is Canada’s first national system of multidisciplinary recognition for the emerging generation of Canadian intellectual leadership. It comprises a fourth entity (along with the current three Academies) within the Royal Society of Canada.  Dr. Langlois’s Laboratory of Molecular Virology and Intrinsic Immunity studies the collection of continuously active mechanisms that protect a host from viral pathogens. Their research interest in the area is threefold: 1) to study the unintended consequences of viral DNA mutagenesis by APOBEC3 proteins; 2) to study how APOBEC3 work and interact with host proteins and nucleic acids; and 3)to develop new technological approaches called Flow Virometry, that enable single particle analysis of viruses.

In honour of the achievement of John Charles Polanyi, recipient of the 1986 Nobel Prize in Chemistry, the Government of the Province of Ontario has established a fund to provide annually up to five prizes to outstanding researchers in the early stages of their career who are continuing to post-doctoral studies or have recently started a faculty appointment at an Ontario university. The main objective of the Lavallée-Adam Lab is to develop computational methods that will lead to a better understanding of cellular mechanisms and diseases processes. These approaches will push the boundary of proteomics applications in systems biology and clinical research. Most importantly, they will provide high quality biomarker signatures and will allow the discovery of novel drug targets for complex disease processes. Dr. Lavallée-Adam’s lab seeks to continuously adapt its computational research to emerging proteomics technologies and to produce innovative algorithms in order to generate novel high impact biomedical discoveries.  Dr. Lavallée-Adam’s research yielded, among other things, software packages for the discovery and confidence assessment of protein-protein interactions and the analysis of the networks formed by these interactions. He also developed algorithms for the analysis of quantitative proteomics data obtained in different experimental conditions and the identification of intact proteins and large polypeptides using mass spectrometry. Finally, his lab’s most recent work aims to develop computational tools for the prediction of drug targets and off-target effects using large-scale mass spectrometry.

As one of the U.S.A.’s oldest learned societies and independent policy research centers, the Academy convenes leaders from the academic, business, and government sectors to address critical challenges facing our global society. Dr. Nemer’s research interests focus on the molecular mechanisms of heart development and function, particularly in relation to heart failure and congenital heart diseases. She is renowned, among other things, for her pioneering work on the regulation of natriuretic heart hormones and the identification of several genes essential for heart development.

The Medal of Honour has been awarded to remarkable individuals whose research or contributions to public policies supportive of research and development in Canada have achieved international recognition. All recipients have made pivotal contribution to the advancement of knowledge in the health sciences and/or the improvement of therapeutics healthcare. Dr. Stiell's research group facilitates practice changing research for both pre-hospital and in-hospital emergency medicine settings. As a part of the Emergency Medicine Research Group led by Dr. Stiell, his research projects are conducted within the most active and productive emergency medicine research program in Canada. Dr. Stiell's current research focus has been on developing clinical decision rules and on clinical trials involving acutely ill patients treated by pre-hospital services and emergency departments. Past research includes internationally recognized clinical decision rules, and a focus on pre-hospital care for cardiac arrest and trauma victims.

The May Cohen Equity, Diversity, and Gender Award recognizes outstanding effort or achievement in improving the gender-equity environment and diversity in academic medicine in Canada. Dr. Darlene Kitty has been presented with this award for her academic leadership in diversity in the recruitment, admission and support of Indigenous students in becoming physicians. An Assistant Professor in the Department of Family Medicine, she teaches and develops Indigenous health curricula including academic activities in Indigenous health and several specialty programs.

The Canada Gairdner Wightman Award recognizes a Canadian health researcher whose career demonstrates extraordinary leadership paired with exceptional science. Throughout his prolific career, Dr. Hakim has been an innovative force for change which has helped take stroke from a dismal condition, to a condition that is preventable, treatable and repairable, bringing hope to stroke survivors and their families. Dr. Hakim is, without a doubt, one of Canada’s most distinguished research pioneers whose legacy will have a profound impact on stroke research and health care. One of Dr. Hakim’s most distinguished accomplishments is the creation, in 2000, of the Canadian Stroke Network (CSN), an initiative funded by the Networks of Centres of Excellence program, with a goal of improving stroke patient care on a national scale. Over a period of 15 years, Dr. Hakim’s CSN not only produced world-class research which led to the development of care guidelines and standards, but it was also remarkably successful at raising public awareness about the potentially debilitating disease. Under Dr. Hakim’s leadership, the CSN unquestionably contributed to reducing stroke mortality and improving stroke recovery.

This award is presented to an exemplary neuromuscular clinician or researcher who has made a significant contribution to neuromuscular research, the advancement of care of people with neuromuscular disorders, or to Muscular Dystrophy Canada in the past year in the areas of public awareness, services and/or fundraising. An internationally renowned thought leader in regenerative medicine, stem cell biology and molecular genetics, Dr. Rudnicki’s groundbreaking research has provided seminal insights into the mechanisms that govern stem cell function, and translated these discoveries towards clinical application. His paradigm-shifting discovery of muscle stem cells transformed our understanding of muscle development and opened the door to new therapeutic strategies to treat neuromuscular disease. His research has fueled the development of novel molecular and stem cell-based approaches for the treatment of muscular dystrophy and other neuromuscular disorders. Dr. Rudnicki’s contributions stand out in a heavily researched field for their clarity and impact on satellite cell function and the wider field of stem cell biology.

The CSMB Arthur Wynne Gold Medal is presented by the Canadian Society for Molecular Biosciences (CSMB) to an individual who has made a major contribution to biochemistry, molecular and cell biology in Canada over their career. The recipient of this life-time achievement award typically has attained an international profile in research, has played a major role in the development and promotion of the discipline in Canada, and has a long-standing record of service to the academic community.  Dr. Nemer’s research interests focus on the molecular mechanisms of heart development and function, particularly in relation to heart failure and congenital heart diseases. She is renowned, among other things, for her pioneering work on the regulation of natriuretic heart hormones and the identification of several genes essential for heart development.

The Early Researcher Awards are awarded to leading researchers in all disciplines to fund a research team for a period of five years. Dr. Benoit is leading an independent research program focused on cancer, stem cell biology, epigenetics, and drug discovery. His group is working to gain a better understanding of fundamental epigenetic phenomenon governing stem cell identity in the human intestinal epithelium and colorectal tumors. One of the main goals of his laboratory at uOttawa is to develop novel, anticancer agents targeting key epigenetic features of colorectal cancer stem cells. Moreover, they aim to tackle the barrier of knowledge regarding the physiological role of chromatin organization in human intestinal stem cell identity and dynamic plasticity.

The Early Researcher Awards are awarded to leading researchers in all disciplines to fund a research team for a period of five years. Dr. Chan’s research program combines leading edge techniques in molecular biology, genetics, and bioinformatics to elucidate the mutation signatures created by high-priority known or suspected carcinogens identified by the International Agency for Research on Cancer (IARC), which is part of the World Health Organization.  With a better understanding of the origin of mutations, it will be possible to devise better cancer prevention, diagnosis, and treatment strategies.